Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "IDA"

1936 News Found

Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr
News | August 11, 2022

Max Healthcare Institute Q1 FY23 consolidated PAT soars at Rs. 172.83 Cr

The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.


Zydus Lifesciences Q1 FY23 consolidated PAT up at Rs. 518.3 Cr
News | August 11, 2022

Zydus Lifesciences Q1 FY23 consolidated PAT up at Rs. 518.3 Cr

The company has reported total income of Rs. 4138.6 crores during the period ended June 30, 2022.


Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr
News | August 10, 2022

Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr

The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.


Unichem Laboratories Q1 FY23 consolidated loss at Rs. 23.36 Cr
News | August 10, 2022

Unichem Laboratories Q1 FY23 consolidated loss at Rs. 23.36 Cr

The company has reported total income of Rs. 317.45 crores during the period ended June 30, 2022


Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr
News | August 09, 2022

Fortis Healthcare posts Q1 FY2023 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 1508.55 crores during the period ended June 30, 2022.


Lupin Q1 FY23 consolidated loss drops to Rs. 89.08 Cr
News | August 04, 2022

Lupin Q1 FY23 consolidated loss drops to Rs. 89.08 Cr

Lupin is the 6th largest company in the Indian Pharmaceutical Market


Poly Medicure Q1FY23 consolidated PAT drops to Rs. 26.96 Cr
News | August 04, 2022

Poly Medicure Q1FY23 consolidated PAT drops to Rs. 26.96 Cr

The company has reported total income of Rs. 253.42 crores during the period ended June 30, 2022.


Fortis Malar Hospitals posts Q1 FY2023 consolidated loss at Rs. 2.96 Cr
News | August 03, 2022

Fortis Malar Hospitals posts Q1 FY2023 consolidated loss at Rs. 2.96 Cr

The company has reported total income of Rs. 21.73 crores during the period ended June 30, 2022.


Jubilant Pharmova posts Q1FY23 consolidated PAT at Rs. 47.04 Cr
News | August 03, 2022

Jubilant Pharmova posts Q1FY23 consolidated PAT at Rs. 47.04 Cr

The company has reported total income of Rs. 1463.03 crores during the period ended June 30, 2022.


Thyrocare Technologies posts Q1FY23 consolidated PAT at Rs. 21.73 Cr
News | August 02, 2022

Thyrocare Technologies posts Q1FY23 consolidated PAT at Rs. 21.73 Cr

The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.